Lobe Sciences Ltd.
LOBEF
$0.0176
-$0.0043-19.64%
OTC PK
02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
---|---|---|---|---|---|
Net Income | 15.58% | 71.84% | -559.90% | 29.33% | -6.54% |
Total Depreciation and Amortization | -- | -- | -100.00% | -1.43% | 1.45% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -47.32% | -87.95% | 2,052.53% | -298.33% | -5.52% |
Change in Net Operating Assets | -35.72% | -9.83% | 33.27% | -56.92% | 27.54% |
Cash from Operations | -45.22% | -1,599.04% | 95.60% | -914.16% | 66.43% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -33.19% | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | -- | -33.52% | -- | -- |
Foreign Exchange rate Adjustments | -296.43% | 1,073.91% | -136.51% | 182.89% | -1,050.00% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 99.42% | -201.45% | 745.00% | 158.25% | 54.96% |